Lipoldová M., Svobodová M., Havelková H., Krulová M., Badalová J., Nohýnková E., Hurt A.A.M., Schlegel D.,Volf P. and Demant P., 2002: Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis. Immunogenetics 54: (3) 174-183.

[ISSN0093-7711]
IF 2.268
GACR310/00/0760

Abstract:
Systematic assessment of the role of host genes in clinico-pathological and immunological manisfestations of Leishmania major-induced disease in mice was performed using 20 recombinant congenic (RC) strains. As the RC strains are homozygous and each carries a different, random set of 12.5% genes from the resistant strain, STS/A, and 87.5% genes from the susceptible strain, BALB/cHeA, they allowed us to study the pathological and immunological characteristics of infected hosts in 20 fixed different random combinations of BALB/c and STS genes. The 20 RC strains differ widely in expression of different symptoms of disease and in immunological characteristics. Disease or healing in different strains occurred in association with different components of immune response - with the exception of a frequently occurring correlation between the disease and IgE levels. Moreover, some parameters of the immune response were highly correlated in some strains but not at all in others. This shows that several patterns of the immune response may be associated with the same clinical outcome, depending on the host genotype. Our data also suggest that despite the complexity of regulation, when a sufficient number of controlling loci is known, the prediction of a phenotype is possible. Combining functional and clinical information with multilocus genotyping may improve our ability to predict the progression of the disease and to optimize the treatment.
Author Keywords:
leishmaniasis; mouse model; complex disease; immune response; genetic regulation ; MAJOR INFECTION; MURINE LEISHMANIASIS; INTERFERON-GAMMA; IMMUNE-RESPONSE; MULTIPLE LOCI; BALB/C MICE; KALA-AZAR; T-CELL; RESISTANCE; SUSCEPTIBILITY